Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-15

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital. It aims to investigate the effect of hand fan therapy on ticagrelor-associated dyspnea in patients receiving ticagrelor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

NCT05549739

Coronary Artery Disease

UNKNOWN

Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)

NCT02650934

Heart Failure and ST Elevation Myocardial Infarction

UNKNOWN

Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome

NCT01249599

Takotsubo Syndrome

COMPLETED

The Incidence of Thoracic Disc Herniation in Patients Presenting With Chronic Upper Back Pain

NCT05313997

Thoracic Disc Herniation

COMPLETED

Mortality Predictors in Coronary Care in Turkey

NCT05296694

Death, Cardiac

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients in the coronary intensive care unit receiving ticagrelor and meeting the inclusion criteria will be included. The study includes two groups: a control group receiving standard care and an experimental group receiving standard care plus hand fan therapy. A total of 110 participants (55 per group) will be recruited. Randomization will be performed using a computer-based randomization program. Due to the nature of the intervention and sample characteristics, participants and the researcher will not be blinded. Data will be analyzed by a statistician not involved in the study, and the findings will be reported.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes Ticagrelor Dyspnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomized into two groups: control and experimental. Randomization will be computer-based. Data will be analyzed by a statistician not involved in the study.

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Outcomes will be assessed by a statistician not involved in the study. Participants and researchers will not be blinded due to the nature of the intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care (Control Group)

Routine ward care including semi-Fowler position and breathing exercises. Standard institutional care will be applied. Presence, number, and severity of dyspnea attacks will be recorded during the first 2 hours after ticagrelor administration.

Group Type ACTIVE_COMPARATOR

STANDART CARE

Intervention Type OTHER

Routine ward care including semi-Fowler position and breathing exercises. Standard institutional care will be applied. Presence, number, and severity of dyspnea attacks will be recorded during the first 2 hours after ticagrelor administration.

Standard Care + Fan Therapy (Experimental Group)

In addition to standard care, patients will undergo hand fanning for 5 minutes at 30, 60, and 120 minutes after ticagrelor administration. The fan will be directed toward the patient's face from a distance of \~15 cm. Dyspnea severity and number of episodes will be recorded during this period.

Device: Hand Fan

Group Type EXPERIMENTAL

STANDART CARE & FAN THERAPY

Intervention Type OTHER

In addition to standard care, patients will undergo hand fanning for 5 minutes at 30, 60, and 120 minutes after ticagrelor administration. The fan will be directed toward the patient's face from a distance of \~15 cm. Dyspnea severity and number of episodes will be recorded during this period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STANDART CARE

Routine ward care including semi-Fowler position and breathing exercises. Standard institutional care will be applied. Presence, number, and severity of dyspnea attacks will be recorded during the first 2 hours after ticagrelor administration.

Intervention Type OTHER

STANDART CARE & FAN THERAPY

In addition to standard care, patients will undergo hand fanning for 5 minutes at 30, 60, and 120 minutes after ticagrelor administration. The fan will be directed toward the patient's face from a distance of \~15 cm. Dyspnea severity and number of episodes will be recorded during this period.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Fan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between the ages of 18 and 65,
* No severe hearing and vision problems,
* Can speak and understand Turkish,
* Easy to communicate with,
* First-time sufferer of acute coronary syndrome (ACS) for the first time,
* Decided to start ticagrelor therapy,
* Able to adapt to treatment,
* Individuals who volunteered to participate in the research.

Exclusion Criteria

* Having any problem that prevents you from communicating cognitively, emotionally and verbally,
* Obstructive sleep abnormalities,
* Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
* With metabolic abnormalities,
* Intubated after the procedure,
* Previously treated with ticagrelor,
* Individuals who did not volunteer to participate in the study. Losses to follow up
* Individuals who wish to leave the study voluntarily.
* Saturation value below 95%,
* The one with the arrest,
* Who will not be able to fulfill the requirements of the work,
* Individuals with life-threatening conditions

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes